The mark consists of the word "LYUMJEV" in dark blue color followed by two diagonal diminishing lines in red and light blue colors.
Mark For: LYUMJEV™ trademark registration is intended to cover the categories of pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain. [all]
>The color(s) dark blue, red, and light blue is/are claimed as a feature of the mark. The mark consists of the word "LYUMJEV" in dark blue color followed by two diagonal diminishing lines in red and light blue colors.
Status
2021-07-25 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type
TRADEMARK
Standard Character Claim
No
Register
PRINCIPAL
Current Location
INTENT TO USE SECTION 2021-02-09
Basis
1(b)
Class Status
ACTIVE
Primary US Classes
005:
Adhesives
006:
Chemicals and Chemical Compositions
018:
Medicines and Pharmaceutical Preparations
044:
Dental, Medical and Surgical Appliances
046:
Foods and Ingredients of Foods
051:
Cosmetics and Toilet Preparations
052:
Detergents and Soaps
Primary International Class
005 - Primary Class
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
No
Current Use
No
Intent To Use
Yes
Filed ITU
Yes
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Attorney Name
Bruce W. Longbottom
Timeline
2020-03-16
Application Filed
2020-03-19
Location: NEW APPLICATION PROCESSING
2020-03-19
Status: Live/Pending
2020-03-19
Transaction Date
2020-06-16
Published
2021-02-09
Location: INTENT TO USE SECTION
2021-07-16
Status: A second request for extension of time to file a Statement of Use has been granted.
BRUCE W. LONGBOTTOM ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS, IN 46285
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases and of oncology and of pain
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
CC0000
The color(s) dark blue, red, and light blue is/are claimed as a feature of the mark.
Trademark Filing History
Description
Date
Proceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-07-20
TEAS EXTENSION RECEIVED
2021-07-16
EXTENSION 2 GRANTED
2021-07-16
98765
EXTENSION 2 FILED
2021-07-16
98765
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2021-02-10
EXTENSION 1 GRANTED
2021-02-09
66230
CASE ASSIGNED TO INTENT TO USE PARALEGAL
2021-02-09
66230
TEAS EXTENSION RECEIVED
2021-01-22
EXTENSION 1 FILED
2021-01-22
66230
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-08-11
PUBLISHED FOR OPPOSITION
2020-06-16
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-06-16
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2020-05-27
ASSIGNED TO EXAMINER
2020-05-09
76986
APPROVED FOR PUB - PRINCIPAL REGISTER
2020-05-09
NOTICE OF DESIGN SEARCH CODE E-MAILED
2020-03-21
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.